Lallemand Health Solutions close a major licensing deal with Proge Farm®

摘要

Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization by Lallemand Health Solutions of Proge Farm®'s established probiotic strain L. plantarum P17630 (Proge 17630®), which has specific women health benefits. "Proge Farm® highly documented probiotic strain L. plantarum P17630 (Proge 17630®), is a valuable new asset in Lallemand Health Solution's Women's health probiotic range. Women's health is gaining more importance in the probiotics market as consumers are increasingly looking for natural ways to take care of their intimate health. Furthermore, with this specific strain, it will be even easier to do so with one daily dose taken orally" declares Isabelle Champte, Vice-President Sales and Marketing at Lallemand Health solutions.